Manual Lymphatic Drainage for Pain, Muscle Strength, and Sensation

Sponsor
Selcuk University (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT06139445
Collaborator
(none)
82
1
2
22
113.4

Study Details

Study Description

Brief Summary

To evaluate the acute effect of MLD on pressure pain threshold (PPT), pain tolerance, tactile sensation, and muscle strength in healthy young adults.

healthy young adults were included in the study. Before and after MLD and plasebo touchs, the same physiotherapist performed PPT and pain tolerance measurements, muscle strength measurements with a hand dynamometer (JamarĀ®) and pinchmeter (BaselineĀ®), and two-point discrimination (2PD) evaluation with an esthesiometer.

Condition or Disease Intervention/Treatment Phase
  • Other: Manual Lymphatic Drainage
  • Other: Plasebo Group
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
82 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Supportive Care
Official Title:
Effect of Manual Lymphatic Drainage on Pressure Pain Threshold, Pain Tolerance, Grip and Pinch Strength, and Two-point Discrimination
Actual Study Start Date :
Nov 8, 2023
Anticipated Primary Completion Date :
Nov 20, 2023
Anticipated Study Completion Date :
Nov 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Study Group

Other: Manual Lymphatic Drainage
Manual lymphatic drainage (MLD), one of the components of complex decongestive physiotherapy, is a gentle massage technique with proven positive effects on lymphatic circulation. MLD can be applied to different parts of the body (e.g., arms, legs, neck, abdomen, and trunk), with a different technique for each region (stationary circle, scoop, pump, and rotary)

Placebo Comparator: Plasebo Group

Other: Plasebo Group
random superficial touches not involved in any manual technique

Outcome Measures

Primary Outcome Measures

  1. pressure pain threshold (PPT) [5 minutes]

    PPT measurements will be performed using a 1-cm2 surface algometer.The algometer will be positioned vertically and placed on the thenar, hypothenar, mid-ulnar, and biceps regions using the marked points. Measurements will be repeated three times. The average of these three measurements will be used for analysis.

  2. pain tolerance [5 minutes]

    pain tolerance measurements will be performed using a 1-cm2 surface algometer.The algometer will be positioned vertically and placed on the thenar, hypothenar, mid-ulnar, and biceps regions using the marked points.The highest tolerable pressure will be used in the measurement and it will be recorded.

  3. Evaluation of Hand Grip Strength [5 minutes]

    The Jamar will be used to measure hand grip strength.Three measurements will be made at one-minute intervals, and the average values will be recorded

  4. Evaluation Finger Pinch Strength [5 minutes]

    A pinchmeter (BaselineĀ®) will be used to measure finger pinch strength. Three measurements will be made at one-minute intervals, and the average values will be recorded

  5. Two-point discrimination (2PD) [10 minutes]

    This evaluation will be performed using an esthesiometer with the participants in the sitting position with their eyes closed. Evaluation will be made from the biceps medial to the elbow. The contact time of the two-point stimulation will be adjusted to be approximately 1-2 seconds, and approximately 3-5 seconds will be waited between each stimulation. The shortest distance felt between two points provided the static 2PD value

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 30 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Being aged 18-30 years

  • Volunteering to participate in the study

Exclusion Criteria:
  • Having any skin disease

  • Having a history of neurological and/or orthopedic disease

  • Having a significant scar or burn tissue in the upper extremity

  • Having any condition that would prevent communication

Contacts and Locations

Locations

Site City State Country Postal Code
1 Selcuk University Konya Turkey 42130

Sponsors and Collaborators

  • Selcuk University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Emine Cihan, Assistant Prof., Selcuk University
ClinicalTrials.gov Identifier:
NCT06139445
Other Study ID Numbers:
  • 2023/25-05
First Posted:
Nov 18, 2023
Last Update Posted:
Nov 18, 2023
Last Verified:
Nov 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Emine Cihan, Assistant Prof., Selcuk University

Study Results

No Results Posted as of Nov 18, 2023